Evidence map›Paper›PMID 40340752›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025

Hierarchical diagnosis of breast phyllodes tumors enabled by deep learning of ultrasound images: a retrospective multi-center study.

Yuqi Yan, Yuanzhen Liu, Yao Wang, Tian Jiang, Jiayu Xie, Yahan Zhou, Xin Liu, Meiying Yan, Qiuqing Zheng, Haifei Xu and 11 more

Abstract readMulticenter Study
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Yuqi Yan *Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, No.1 East Banshan Road, Gongshu District, Hangzhou, Zhejiang, 310022, China.
Yuanzhen Liu *Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, No.1 East Banshan Road, Gongshu District, Hangzhou, Zhejiang, 310022, China.
Yao WangDepartment of Ultrasound, Lishui People's Hospital, Lishui, Zhejiang, China.
Tian JiangDepartment of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, No.1 East Banshan Road, Gongshu District, Hangzhou, Zhejiang, 310022, China.
Jiayu XiePostgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.
Yahan ZhouWenling Institute of Big Data and Artificial Intelligence Institute in Medicine, No.18, Civic Avenue, Wenling, Taizhou, Zhejiang, 317502, China.
Xin LiuDepartment of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, No.1 East Banshan Road, Gongshu District, Hangzhou, Zhejiang, 310022, China.
Meiying YanDepartment of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, No.1 East Banshan Road, Gongshu District, Hangzhou, Zhejiang, 310022, China.
Qiuqing ZhengDepartment of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, No.1 East Banshan Road, Gongshu District, Hangzhou, Zhejiang, 310022, China.
Haifei XuDepartment of Ultrasound, Lishui People's Hospital, Lishui, Zhejiang, China.
Jinxiao ChenDepartment of Ultrasound, Lishui People's Hospital, Lishui, Zhejiang, China.
Lin SuiDepartment of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, No.1 East Banshan Road, Gongshu District, Hangzhou, Zhejiang, 310022, China.
Chen ChenDepartment of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, No.1 East Banshan Road, Gongshu District, Hangzhou, Zhejiang, 310022, China.
RongRong RuDepartment of Ultrasound, Zhejiang Xiaoshan Hospital, Hangzhou, Zhejiang, China.
Kai WangDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.
Anli ZhaoDepartment of Ultrasound, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.
Shiyan LiDepartment of Ultrasound in Medicine, Affiliated Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Ying Zhu *Department of Ultrasound, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, No.197, Ruijin 2nd Road, Huangpu District, Shanghai, Zhejiang, 200025, China. zhuying_rj@126.com.
Yang Zhang *Wenling Institute of Big Data and Artificial Intelligence Institute in Medicine, No.18, Civic Avenue, Wenling, Taizhou, Zhejiang, 317502, China. yangz17@myyahoo.com.
Vicky Yang Wang *Wenling Institute of Big Data and Artificial Intelligence Institute in Medicine, No.18, Civic Avenue, Wenling, Taizhou, Zhejiang, 317502, China. wangyang@waiim.org.cn.
Dong Xu *Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, No.1 East Banshan Road, Gongshu District, Hangzhou, Zhejiang, 310022, China. xudong@zjcc.org.cn.

Funding

The Pioneer and Leading Goose R&D Program of Zhejiang 2023C04039the project of Jinhua Science and Technology Bureau 20234225
6 · The paper itself

Abstract

objectivePhyllodes tumors (PTs) are rare breast tumors with high recurrence rates, current methods relying on post-resection pathology often delay detection and require further surgery. We propose a deep-learning-based Phyllodes Tumors Hierarchical Diagnosis Model (PTs-HDM) for preoperative identification and grading.

methodsUltrasound images from five hospitals were retrospectively collected, with all patients having undergone surgical pathological confirmation of either PTs or fibroadenomas (FAs). PTs-HDM follows a two-stage classification: first distinguishing PTs from FAs, then grading PTs into benign or borderline/malignant. Model performance metrics including AUC and accuracy were quantitatively evaluated. A comparative analysis was conducted between the algorithm's diagnostic capabilities and those of radiologists with varying clinical experience within an external validation cohort. Through the provision of PTs-HDM's automated classification outputs and associated thermal activation mapping guidance, we systematically assessed the enhancement in radiologists' diagnostic concordance and classification accuracy.

resultsA total of 712 patients were included. On the external test set, PTs-HDM achieved an AUC of 0.883, accuracy of 87.3% for PT vs. FA classification. Subgroup analysis showed high accuracy for tumors < 2 cm (90.9%). In hierarchical classification, the model obtained an AUC of 0.856 and accuracy of 80.9%. Radiologists' performance improved with PTs-HDM assistance, with binary classification accuracy increasing from 82.7%, 67.7%, and 64.2-87.6%, 76.6%, and 82.1% for senior, attending, and resident radiologists, respectively. Their hierarchical classification AUCs improved from 0.566 to 0.827 to 0.725-0.837. PTs-HDM also enhanced inter-radiologist consistency, increasing Kappa values from - 0.05 to 0.41 to 0.12 to 0.65, and the intraclass correlation coefficient from 0.19 to 0.45.

conclusionPTs-HDM shows strong diagnostic performance, especially for small lesions, and improves radiologists' accuracy across all experience levels, bridging diagnostic gaps and providing reliable support for PTs' hierarchical diagnosis.

Indexed as

Breast NeoplasmsDeep LearningPhyllodes TumorUltrasonography, MammaryAdultFemaleFibroadenomaHumansMiddle AgedRetrospective StudiesBreastDeep learningFibroadenomaPhyllodes tumorsUltrasound

Identifiers

PMID40340752
PMCPMC12063467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.